The valve, designed with a new-look sealing cuff for limiting paravalvular regurgitation, gained FDA approval in January 2023. 

In a new video interview, Stephanie Golab, MD, examines the latest data on heart transplant outcomes in older adults.

The heart of a 43-year-old prisoner is still missing nearly eight weeks after he was found dead at Ventress Correctional Facility in Alabama. A judge heard from five witnesses on Jan. 5, but made little progress on solving the mystery.

According to CEO Sabine Bois, a veteran of the medical device industry, this approval represents a "significant leap forward" in the company's commitment to heart patients. 

Advanced AI models can evaluate a patient's heart failure risk using 12-lead ECG data—but there is still some room for improvement. 

Renee Bullock-Palmer, MD, details the latest guidelines that support the continued use of CT angiography.

The two devices, already approved by the FDA, were designed with batteries expected to last more than 15 years. 

The veteran interventional cardiologist was initially sentenced to five years in prison for healthcare fraud. After multiple appeals and some significant updates, however, he was granted a new trial. 

A hybrid approach may increase the risk of certain adverse events, according to a new meta-analysis focused on long-term outcomes. 

The company's Verafeye platform was designed to provide imaging guidance during cardiac procedures using advanced catheter sensors and deep learning. 

The victim has yet to be identified in an ongoing murder investigation in Cincinnati.

Varian said it plans to work closely with Nova Scotia Health to develop a new "digital imaging concept," the two organizations announced Jan. 4.